Analyst Research: Pharmaceutical Product Development (PPDI.O)
PPDI.O on Nasdaq
21.36USD
10 Dec 2009
21.36USD
10 Dec 2009
Price Change (% chg)
$0.09 (+0.42%)
$0.09 (+0.42%)
Prev Close
$21.27
$21.27
Open
$21.29
$21.29
Day's High
$21.51
$21.51
Day's Low
$21.29
$21.29
Volume
722,270
722,270
Avg. Vol
957,921
957,921
52-wk High
$29.53
$29.53
52-wk Low
$17.97
$17.97
| Name | Age | Since | Current Position |
|---|---|---|---|
| Eshelman, Fredric | 60 | 2009 | Executive Chairman of the Board |
| Grange, David | 60 | 2009 | Chief Executive Officer, Director |
| Darazsdi, Daniel | 48 | 2007 | Chief Financial Officer, Treasurer, Assistant Secretary |
| Sharbaugh, William | 46 | 2007 | Chief Operating Officer |
| Wilkinson, Mike | 54 | 2008 | Executive Vice President - Global Clinical Development |
- UPDATE 1-Charles River posts lower Q3 profit, cuts 2009 EPS view
- UPDATE 1-PPD Q3 EPS meets Street, cuts '09 view on poor bookings
- UPDATE 1-Charles River posts lower Q2 profit, cuts '09 rev view
- UPDATE 1-PPD shrs fall on weak bookings and high cancellations
- PPD shares fall on weak new business and high cancellations
© Copyright 2009 Thomson Reuters
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
